Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ANTX

ANTX News

Newswire

16:24

AN2 Therapeutics Reports Q3 Financial Results, Advances Chagas Disease Program

16:03

AN2 Therapeutics Reports Q3 2025 Financial Results and Recent Business Highlights, Including Progress in Oral AN2-502998 for Chagas Disease and Oncology Programs

07:28

AN2 Therapeutics shares rise 21.05% premarket after announcing GSK collaboration and Gates funding for TB treatment development.

07:17

AN2 Therapeutics shares jump 14.91% premarket after announcing GSK collaboration and Gates Foundation funding for TB drug development.

07:04

GSK and AN2 Therapeutics Collaborate to Advance Boron-Based LeuRS-Inhibitors for TB Treatment

View More

About ANTX

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More